Inventiva S.A.
IVANasdaqHealthcare · Pharmaceutical Preparations · I0 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Deep Track Capital, LpPassive (13G)May 15, 2026
- New Enterprise Associates 17, L.P.Activist (13D)Apr 1, 2026
- Andera PartnersPassive (13G)Feb 17, 2026
- Great Point Partners LlcPassive (13G)Feb 17, 2026
- Sofinnova Crossover IPassive (13G)Feb 17, 2026
- Eventide Asset Management, LlcPassive (13G)Feb 13, 2026
- Samsara Biocapital, L.P.Activist (13D)Nov 19, 2025
- Biotechnology Value Fund L PActivist (13D)Nov 19, 2025
- Perceptive Advisors LlcPassive (13G)Nov 14, 2025
- Yiheng Capital Management, L.P.Passive (13G)Nov 13, 2025
- Invus Global Management, LlcPassive (13G)Jul 31, 2025
- Broqua PierrePassive (13G)Feb 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 608,949 | 2.1 | -5.2% |
| Apr 30, 2026 | 642,216 | 2.8 | +46.6% |
| Apr 15, 2026 | 438,164 | 1.0 | -2.6% |
| Mar 31, 2026 | 449,688 | 1.6 | +0.6% |
| Mar 13, 2026 | 447,124 | 1.5 | -18.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 6-KFORM 6-KMay 26, 2026
- 6-KFORM 6-KMay 22, 2026
- SCHEDULE 13G/AMay 15, 2026
- 6-KFORM 6-KApr 22, 2026
- 20-FApr 8, 2026
- SCHEDULE 13D/AApr 1, 2026
- 6-KFORM 6-KMar 30, 2026
- SCHEDULE 13G/AFeb 17, 2026
- SCHEDULE 13G/AFeb 17, 2026
- SCHEDULE 13G/AFeb 17, 2026
- 6-KFORM 6-KFeb 17, 2026
- SCHEDULE 13G/AFeb 13, 2026
- SCHEDULE 13GJan 30, 2026
- 6-KFORM 6-KNov 28, 2025
- 6-KFORM 6-KNov 24, 2025